Clinical trials: Suicidal Ideation
Major Depressive Disorder
A Randomized, Double-Blind, Placebo-Controlled, Sequential Parallel Study of CERC-301 in the Adjunctive Treatment of Subjects With Severe Depression and Recent Active Suicidal Ideation Despite Antidepressant Treatment
The current study will evaluate the antidepressant effect of CERC-301 during 28 days of treatment in subjects with MDD who are currently experiencing a severe depressive episode despite stable ongoing treatment with selective…
- Trial name
- NCT01941043
- Testing
- CERC-301
- Where
- 24 sites in United States
- Volunteers
- 1,357 people
- Sponsor
- Avalo Therapeutics, Inc.